Tag: 690 nm | Page 4

Breaking the selectivity‑uptake trade‑off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi‑tier cancer targeting

Scientific papers / 690 nm, BPD, cancer, cetuximab, in vitro, liposomes, ML6600, PIC-Nal, targeted photoimmunotherapy, targeted therapies / January 2, 2020

Published in: Journal of Nanobiotechnology Authors: Barry J. Liang, Michael Pigula, Yan Baglo, Daniel Najafali , Tayyaba Hasan, Huang‑Chiao Huang

Breaking the selectivity‑uptake trade‑off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi‑tier cancer targeting Read More »

Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells

Scientific papers / 690 nm, benzoporphyrin derivative, BPD, breast, in vitro, ML6600, ML8500, PDT, Photodynamic therapy, photosensitizer / August 10, 2019

Published in: Cancer Letters Authors: Yan Baglo, Barry J. Liang, Robert W. Robey, Suresh V. Ambudkar, Michael M. Gottesman, Huang-Chiao Huang

Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells Read More »

An Infrared Dye–Conjugated Virus-like Particle for the Treatment of Primary Uveal Melanoma

Scientific papers / 690 nm, choroidal melanoma, in vitro, in vivo, IRDye700, ML6600, MLAKIT, ophthalmology, PDT, tumor, Uveal Melanoma / February 1, 2018

Published in: Molecular Cancer Therapeutics Authors: Rhonda C. Kines, Isabella Varsavsky, Sanghamitra Choudhary, Debaditya Bhattacharya, Sean Spring, Roger McLaughlin, Shin J. Kang, Hans E. Grossniklaus, Demetrios Vavvas, Stephen Monks, John R. MacDougall, Elisabet de los Pinos, and John T. Schiller

An Infrared Dye–Conjugated Virus-like Particle for the Treatment of Primary Uveal Melanoma Read More »

EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer

Scientific papers / 690 nm, H&N cancer, head & neck cancer, IRDye700, ML7710, PDT, Photodynamic therapy, preclinical, targeted therapies / May 10, 2016

Published in: Journal of Controlled Release Authors: Pieter B.A.A. van Driel, Martin C. Boonstra, Maxime D. Slooter, Raimond Heukers, Marieke A. Stammes, Thomas J.A. Snoeks, Henriette S. de Bruijn, Paul J. van Diest, Alexander L. Vahrmeijer, Paul M.P. van Bergen en Henegouwen, Cornelis J.H. van de Velde, Clemens W.G.M. Löwik, Dominic J. Robinson, Sabrina Oliveira

EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer Read More »